ADALIMUMAB-BWWD for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 33 adverse event reports in the FDA FAERS database where ADALIMUMAB-BWWD was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-BWWD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 95 | 13.1% | 0 | 6 |
| Off label use | 64 | 8.9% | 1 | 20 |
| Drug ineffective | 60 | 8.3% | 0 | 15 |
| Fatigue | 48 | 6.6% | 0 | 14 |
| Arthralgia | 46 | 6.4% | 0 | 10 |
| Device issue | 42 | 5.8% | 0 | 3 |
| Rheumatoid arthritis | 42 | 5.8% | 0 | 5 |
| Product substitution issue | 40 | 5.5% | 0 | 2 |
| Accidental exposure to product | 37 | 5.1% | 0 | 2 |
| Exposure via skin contact | 34 | 4.7% | 0 | 2 |
| Pain | 34 | 4.7% | 2 | 9 |
| Headache | 32 | 4.4% | 0 | 7 |
| Rash | 32 | 4.4% | 0 | 5 |
| Wrong technique in product usage process | 32 | 4.4% | 0 | 1 |
| Injection site bruising | 31 | 4.3% | 0 | 2 |
Other Indications for ADALIMUMAB-BWWD
Rheumatoid arthritis (174)
Crohn's disease (134)
Product used for unknown indication (94)
Psoriatic arthropathy (78)
Ankylosing spondylitis (62)
Hidradenitis (37)
Uveitis (37)
Colitis ulcerative (32)
Sarcoidosis (7)
Arthritis (6)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)